메뉴 건너뛰기




Volumn 373, Issue 16, 2015, Pages 1580-1582

Response to idelalisib in a patient with stage IV Merkel-cell carcinoma

Author keywords

[No Author keywords available]

Indexed keywords

IDELALISIB; ANTINEOPLASTIC AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PIK3CA PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR; PURINE DERIVATIVE; QUINAZOLINONE DERIVATIVE;

EID: 84944447424     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1507446     Document Type: Letter
Times cited : (38)

References (5)
  • 2
    • 84863277615 scopus 로고    scopus 로고
    • Activation of PI3K signaling in Merkel cell carcinoma
    • Nardi V, Song Y, Santamaria-Barria JA, et al. Activation of PI3K signaling in Merkel cell carcinoma. Clin Cancer Res 2012; 18:1227-36.
    • (2012) Clin Cancer Res , vol.18 , pp. 1227-1236
    • Nardi, V.1    Song, Y.2    Santamaria-Barria, J.A.3
  • 4
    • 84896765296 scopus 로고    scopus 로고
    • Idelalisib - A PI3Kδ inhibitor for B-cell cancers
    • Fruman DA, Cantley LC. Idelalisib - a PI3K inhibitor for B-cell cancers. N Engl J Med 2014;370:1061-2.
    • (2014) N Engl J Med , vol.370 , pp. 1061-1062
    • Fruman, D.A.1    Cantley, L.C.2
  • 5
    • 84903188335 scopus 로고    scopus 로고
    • Inactivation of PI(3)K p110 breaks regulatory T-cell-mediated immune tolerance to cancer
    • Ali K, Soond DR, Piñeiro R, et al. Inactivation of PI(3)K p110 breaks regulatory T-cell-mediated immune tolerance to cancer. Nature 2014;510:407-11.
    • (2014) Nature , vol.510 , pp. 407-411
    • Ali, K.1    Soond, D.R.2    Piñeiro, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.